To ask the Secretary of State for Business, Energy and Industrial Strategy, where vaccine doses purchased in the agreements with (a) BioNTech and (b) Pfizer will be manufactured.
7 September 2020
BioNTech and Pfizer have come together to develop a vaccine based on BioNTech’s proprietary mRNA technology and supported by Pfizer’s global vaccine development and manufacturing capabilities. A deal to supply 30m doses to the UK was announced 20 July 2020. As commercial negotiations are still ongoing around the vaccine agreements at this time, the Government is not able to confirm manufacturing and supply arrangements at present.